Yamazaki smiled bitterly and found that he seemed to have never taken advantage of the competition between him and An Tianmin Company and Liang Sanping. Of course, he did not seem to suffer any losses after the contract was formulated.

Thinking of this, Yamazaki couldn't help but smile bitterly. Now Xia Zhendong and others have obviously learned a lot of methods from Liang Sanping, and the negotiation points are all tied to Wan Hong's key points, but they still leave you profits. It's not that I asked you to refuse, but I agree but feel at a loss.

"One of our parties will first conduct joint tests after the breeding experiment is successful. Especially in terms of drug treatment effects, we can discharge experts and even conduct clinical trials in Japan..."

Yamazaki kept recording the cooperation proposed by Xia Zhendong and others and nodded frequently. After all, the medicines and supplements that Liang Sanping and others developed based on the ancient Chinese medicine prescriptions must eventually be sold to the Japanese market through Japanese companies.

If they want to sell it to Europe and the United States, Japan will definitely have an advantage over Liang Sanping and others. The simplest thing is, there is a lot of experience in applying for FDA.

This is completely different from Liang Sanping and others. There is a reason why Liang Sanping is eager to make Chinese medicine now. Because he knows that in the future, the traditional Chinese medicine that was once criticized by Chinese people will be in a huge foreign market.

In China, traditional Chinese medicine has been criticized a lot. Some people even denounced traditional Chinese medicine as the so-called "pseudoscience". Some people fueled the fire, and seemed to not stop until they could end the end of their Chinese medicine or publicize the prescription.

Some of these people pretend to understand with ignorance, while more people pretend to be confused with ignorance. The reason is very simple, because by 2009, China's clinical summary of secret recipes has reached more than 300,000, more than 60,000 records, and 35 categories of patent medicines. There are 43 dosage forms, and secret recipes of traditional Chinese medicine have become an important source of new drug development.

At the same time, Japan, South Korea and other countries are working hard to develop traditional Chinese medicine. They purchase raw materials from China at a low price and then perform fine processing, and then sell them to all parts of the world at a price dozens or even hundreds of times higher than domestic traditional Chinese medicine.

For example, the "Heart-relieving Pills" produced in Japan were developed based on my country's "Liu Shen Pills" with annual sales of over 100 million US dollars; South Korea's "Niuhuang Qingxin Liquid" originated from my country's "Niuhuang Qingxin Pills" with annual output value of nearly 100 million US dollars.

As of 2009, more than 900 Chinese medicines have been criticized by many Chinese people and have been patented by foreign companies.

Since April 1992, Koreans have successively applied for invention patents such as beef purse Qingxin Liquid, beef purse Qingxin Micro Capsules and beef purse Qingxin Pills New Prescription Composition from patent offices in Korea, China, Japan and the United States. They have seized Tongrentang's domestic and foreign markets with new dosage forms and new process patents. Among them, the annual output value of the beef purse Qingxin Liquid alone reaches US$70 million!

Not only that, Korean traditional Chinese medicine directly changed "Traditional Chinese medicine" to Korean medicine in 1980. Compared with Japan, there are fewer Chinese medicine varieties in South Korea, about 100, but South Korea is more specialized than Japan in the development of traditional Chinese medicine.

The most typical one is Korean specialty Korean ginseng. According to statistics, among the same grade Korean ginseng exports, Korean products are 28 times more expensive than China! All of this made Liang Sanping extremely heartbroken and helpless.

What is more noteworthy is that the export volume of Chinese patent medicines showed its first deficit in 13 years in 2008, which means that the export is small but the import is large. The most exports we export are low-profit Chinese medicinal materials. Japanese and Korean companies imported our Chinese medicinal materials and then deep processing them, and finally made high-profit Chinese patent medicines and then exported them.

What’s ridiculous is that as the country of origin of traditional Chinese medicine, it has been questioned and criticized. So much so that China eventually became a place for raw materials for traditional Chinese medicine, while Japan and South Korea made huge profits abroad with these traditional Chinese medicines that were abandoned by the Chinese people.

Some media are constantly criticizing "formula protection" and trying to let many protected ancient prescriptions announce their prescriptions. Once these prescriptions are announced as they wish, they will only get the advantage of Japan and South Korea.

Our export ability is not as good as others, and our experience in obtaining sales qualifications is not as good as others. The ultimate consequence is that our patents are registered abroad by these Japanese and Korean companies, and then happily make a lot of money with the capital left by our ancestors.

These people may be pretending to understand. But maybe... more people are pretending to be foolish. There are even some people who have taken certain benefits and have come forward to incite and provoke such things.

"Our traditional Chinese medicine and Chinese medicine must occupy a place in the international market! Not only Japan, South Korea, but more so Europe and the United States, where we have a huge consumer market!"

But Liang Sanping smiled and said to Zhou Jie and others: "In the theory of traditional Chinese medicine, there is a saying that 'the best cures before illness, traditional Chinese medicine treats desire illness, and the next medicine treats already illness', which fully demonstrates our emphasis on daily health conditioning..."

"And what we are specializing in now is this aspect. We need to make certain 'dietary supplements', which is dietary supplements according to our words..."

If you try to directly get traditional Chinese medicine into the United States, it will undoubtedly be extremely difficult. The simplest funding problem can make Liang Sanping feel a headache. If you successfully register a new drug in the United States, you must pass multiple stages of application for clinical research of new drugs, first phase clinical trials, second phase clinical trials, third phase clinical trials, and new drug registration application.

The above five items will cost no less than 8 years or more, and hundreds of millions of dollars. If you want to count the failure in the middle, the average pre-market cost of a new drug may reach 800 million US dollars!

For $800 million, Liang Sanping will get so much money unless he robs the treasury?! As a dietary supplement, try the water first. This is the best way and the easiest way.

In fact, this is also the decision made by Liang Sanping after considering it for a long time. An Tianmin is still too poor now, and it is difficult for Liang Sanping to do something. If Chinese medicine directly tries to enter the US market, it will definitely cause boycott and embarrassment from traditional Chinese medicine companies, including Japan and South Korea. Even local pharmaceutical companies in the United States will come to cause trouble.

There are examples like this. Under the strong publicity offensive of Xuezhikang Capsules, Cholestin has entered 35,000 supermarkets across the United States, including Walmart.

The mainstream sales channels, coupled with the price of several hundred dollars cheaper than Western medicine, have increased the export trade volume of special red citrus, which costs tens of thousands of dollars per ton, and sold hundreds of tons throughout the year in 1999.

Just as Americans were immersed in spending very little money but getting the same satisfactory efficacy as Western medicine, some Western medicine manufacturers began to make "small reports" to FDA, saying that cholestin is not a health product, but a drug.

So, FDA went to court with the American health products company. Although the first and second instance companies won, the 2001 US Supreme Court rule finally stopped Cholestin's sales in the United States.

In the current United States, there is no clear definition of botanical medicine, so many Chinese medicines that are all plant-based in the future are sold under the name of "dietary supplements".

It is not impossible to sell traditional Chinese medicine as food supplements, but if your sales affect Western medicine, the consequence is... like Cholestin's big sale, Western medicine manufacturers are sued for their own interests when their own interests are damaged.

Liang Sanping didn't want to touch this brow, but the concept of "treatment before illness" in traditional Chinese medicine can be used at this time. It is OK to enter the US market on the grounds of nutrition and dietary supplements.

Moreover, this will not affect the original interests of Japan, South Korea and other countries in Europe, the United States and other places. Only after the time is enough and the US FDA's way can Liang Sanping launch an action to push traditional Chinese medicine into the US market.

"What we need now is a stepping stone. If this stepping stone is done, we can successfully open up the European and American markets, and even expand our country's influence in Europe and the United States, and promote traditional medicine."

Liang Sanping looked at Zhou Jie and others solemnly and said, "In 1980, the Koreans actually changed the traditional Chinese medicine that we passed on to "Korean Medicine"! This incident made me feel extremely heartbroken..."

"The treasures passed down by our ancestors for thousands of years, but when we come here, it will become someone else's. If we don't chase them up and protect the treasures passed down by our ancestors, perhaps not many years later, people in the world only know "Korean medicine" and "Korean medicine", and no longer know that their names were originally called "Traditional medicine"..."

Liang Sanping's words made Zhou Jie and others furious. At this time, the country was still isolated from the outside world. They didn't know the situation outside, and they didn't even know that Chinese medicine was called "Korean medicine" in South Korea.

"These gang of damn Goryeo sticks! So shameless!!" Zhou Jie suddenly stood up and roared angrily, and the other traditional Chinese medicine researchers also looked extremely ugly.

Several of them were skilled prescriptions handed down from generation to generation. If they were really made by Koreans, then to put it bluntly, they would have no shame to see their ancestors even if they died.

"Sanping! Don't worry, we will do our best to do our best in this matter! You can't let those sticks take advantage of us!" But Zhou Jie said viciously: "When it comes to traditional Chinese medicine, we are their ancestors! The little ability of the Japanese is to develop from "Treatise on Febrile Diseases". The prescriptions in our hands are much better than them!"

Liang Sanping nodded solemnly. He held this meeting with Zhou Jie and others specifically to tell them the current situation of traditional Chinese medicine. If there is no protection and development, then those who are waiting for traditional Chinese medicine may gradually disappear...

In the end, China, as the birthplace of traditional Chinese medicine, can only become a source of other people's Chinese medicine... (To be continued, please search Piaotianwen, novels are better and faster!

...
Chapter completed!